Literature DB >> 22833082

Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates.

Marcus Dabner1, W Glenn McCluggage, Chris Bundell, Aisling Carr, Yee Leung, Raghwa Sharma, Colin J R Stewart.   

Abstract

Anti-N-methyl D-aspartate receptor (NMDAR) encephalitis is a recently described severe neurological disorder predominantly affecting young women, which presents with psychosis, memory deficits, seizures, and encephalopathy, often requiring prolonged hospitalization. The condition is frequently associated with an underlying neoplasm, most often an ovarian teratoma, and in such cases appears to be a para-neoplastic, immune-mediated encephalopathy. The histologic features of the teratomas associated with anti-NMDAR encephalitis have seldom been described in detail. Therefore, in this report, we have compared ovarian teratomas (4 mature and 1 immature) from 5 patients with anti-NMDAR encephalitis with 22 sporadic control teratomas (14 mature and 8 immature) that included neuroglial elements. The encephalitis-associated tumors ranged from 0.7 to 9.5 cm diameter, and 1 case was bilateral; the second teratoma was discovered 13 mo after the first when symptoms recurred. In comparison with control teratomas, the anti-NMDAR-associated tumors showed a more marked intratumoral lymphoid infiltrate that colocalized to the mature neuroglial elements. Reactive germinal centers (3 cases) and diffuse lymphoplasmacytic infiltrates within the neuroglial matrix (4 cases), and degenerative neuronal changes (2 cases), were seen only in the anti-NMDAR-positive cases. Pathologists encountering ovarian teratomas with these distinctive reactive lymphoid elements should consider the possibility of anti-NMDAR encephalitis, particularly because the neurological symptoms may develop after tumor resection. Careful histopathologic examination may be required to identify small, radiologically occult teratomas, and to demonstrate the presence of subtle neoplastic neuroglial components in teratomas associated with anti-NMDAR encephalitis.

Entities:  

Mesh:

Year:  2012        PMID: 22833082     DOI: 10.1097/PGP.0b013e31824a1de2

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  16 in total

1.  Clinical characteristics, treatment and long-term prognosis in patients with anti-NMDAR encephalitis.

Authors:  Pritam Raja; Biswas Shamick; L K Nitish; Vikram Venkappayya Holla; P K Pal; Anita Mahadevan; Priya Treesa Thomas; Bhat Maya; J Saini; H Shantala; M Netravathi
Journal:  Neurol Sci       Date:  2021-03-16       Impact factor: 3.307

2.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

3.  Incidence of intracranial germ cell tumors by race in the United States, 1992-2010.

Authors:  Jenny N Poynter; Rachel Fonstad; Jakub Tolar; Logan G Spector; Julie A Ross
Journal:  J Neurooncol       Date:  2014-08-03       Impact factor: 4.130

4.  Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Authors:  Chloé Bost; Eve Chanson; Géraldine Picard; David Meyronet; Marie-Eve Mayeur; François Ducray; Veronique Rogemond; Dimitri Psimaras; Jean-Christophe Antoine; Jean-Yves Delattre; Virginie Desestret; Jerome Honnorat
Journal:  J Neurol       Date:  2018-07-12       Impact factor: 4.849

5.  Rapid recovery from catastrophic paraneoplastic anti-NMDAR encephalitis secondary to an ovarian teratoma following ovarian cystectomy.

Authors:  Charuwan Tantipalakorn; Atiwat Soontornpun; Tip Pongsuvareeyakul; Theera Tongsong
Journal:  BMJ Case Rep       Date:  2016-08-10

Review 6.  Autoantibodies in neurological disease.

Authors:  Harald Prüss
Journal:  Nat Rev Immunol       Date:  2021-05-11       Impact factor: 53.106

7.  Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases.

Authors:  Pedro Acién; Maribel Acién; Eva Ruiz-Maciá; Carlos Martín-Estefanía
Journal:  Orphanet J Rare Dis       Date:  2014-10-14       Impact factor: 4.123

8.  N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications.

Authors:  Mateusz Makuch; Robert Wilson; Adam Al-Diwani; James Varley; Anne-Kathrin Kienzler; Jennifer Taylor; Antonio Berretta; Darren Fowler; Belinda Lennox; M Isabel Leite; Patrick Waters; Sarosh R Irani
Journal:  Ann Neurol       Date:  2018-03       Impact factor: 10.422

9.  N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit.

Authors:  Nina Kerstin Wenke; Jakob Kreye; Ewa Andrzejak; Adriana van Casteren; Jonas Leubner; Manuela S Murgueitio; S Momsen Reincke; Christopher Secker; Lars Schmidl; Christian Geis; Frauke Ackermann; Marc Nikolaus; Craig C Garner; Hedda Wardemann; Gerhard Wolber; Harald Prüss
Journal:  Ann Neurol       Date:  2019-04-02       Impact factor: 10.422

10.  Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.

Authors:  Xin-Yue Jiang; Song Lei; Le Zhang; Xu Liu; Min-Tao Lin; Ingmar Blumcke; Yue-Shan Piao; Dong Zhou; Jin-Mei Li
Journal:  Acta Neuropathol Commun       Date:  2020-08-08       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.